ACS Synthetic BiologySynthetic BiologyPeer-reviewed journal article
Receptor-guided AAV Tropism Engineering via MATCH
Nolan GrahamiD, Satheesh KumariD, Joseph RainaldiiD, Seoin Yang, Andrew J. PortelliD, Billy Santoso, Prashant MaliiD
Abstract
Precise control over viral tropism remains a major challenge in the development of gene delivery technologies. We present MATCH (Modulation of AAV Tropism through Conjugation to Homing proteins), a modular biochemical method that enables programmable, receptor-guided retargeting of adeno-associated viruses (AAVs) through site-specific covalent protein conjugation. By incorporating a SpyTag peptide motif into selected AAV capsid loops, MATCH allows one-step, stoichiometrically defined attachment of recombinant SpyCatcher-linked targeting proteins to the viral surface. Using mosaic AAV-DJ and AAV9 capsids with controlled SpyTag incorporation, we achieve efficient assembly and tunable ligand display. MATCH-AAVs conjugated to an anti-CD3 single-chain antibody efficiently activate and transduce resting human T cells within mixed PBMC populations in vitro, achieving transduction levels of up to [~]58% of total PBMCs. Conjugation to transferrin receptor (TfR1)-binding proteins yielded enhanced brain transduction in vivo, with murine TfR1-targeted MATCH-AAV9 exhibiting up to an 84-fold increase in brain expression relative to wild-type AAV9. Human TfR1-targeted vectors similarly enabled robust, receptor-dependent transduction both in vitro and in humanized mouse models. Both TfR-targeted vectors enabled widespread transduction of the parenchyma, consistent with TfR1-mediated crossing of the blood-brain barrier. Finally, we establish a streamlined one-pot "Mix-and-MATCH" production strategy in which capsid and targeting ligands are co-expressed during vector generation, yielding functional, targeted AAVs at titers comparable to conventional production. This simple and generalizable synthetic-biology approach provides a versatile toolkit for rational AAV tropism engineering, offering a scalable route to custom vector design for research and therapeutic applications. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=106 SRC="FIGDIR/small/715691v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@1935815org.highwire.dtl.DTLVardef@7c05faorg.highwire.dtl.DTLVardef@6c8857org.highwire.dtl.DTLVardef@16b2097_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- organism: mouse
- research focus: drug response / drug discovery
- research focus: protein design
- approach: experimental assay
- Citations
- 2
- FWCI
- 8.01
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A facile chemical strategy to synthesize precise AAV-protein conjugates for targeted gene delivery
Quan Thanh Pham, Jake Glicksman, … Abhishek Chatterjee·Molecular Therapy OncologyPeer-reviewed·Aug 23, 2025
- Targeting AAV vectors to the CNS via de novo engineered capsid-receptor interactions
Qin Huang, Albert Tian Chen, … Benjamin E. Deverman·bioRxiv·Oct 31, 2022
- Precise manipulation of site and stoichiometry of capsid modification enables optimization of functional adeno-associated virus conjugates
Sarah B. Erickson, Quan Thanh Pham, … Abhishek Chatterjee·Bioconjugate ChemistryPeer-reviewed·Dec 16, 2023
- Genetically encoded SpyTag enables modular AAV retargeting via SpyCatcher-fused ligands for targeted gene delivery.
Anja Armbruster, Maximilian Hörner, … Wilfried Weber·ACS Synthetic BiologyPeer-reviewed·Dec 22, 2025
- Reprogramming Adeno-Associated Virus Tropism Via Displayed Peptides Tiling Receptor-Ligands
A. Portell, K. M. Ford, … P. Mali·bioRxiv·Sep 26, 2022
- Structural basis of liver de-targeting and neuronal tropism of CNS-targeted AAV capsids
Tyler J. Brittain, Seongmin Jang, … Viviana Gradinaru·Molecular TherapyPeer-reviewed·Mar 28, 2026